Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CLINICAL-DATA AND ANIMAL STUDIES ON ADAPTIVE RECEPTOR CHANGES OCCURRING IN DEPRESSION AND AFTER ANTIDEPRESSIVE TREATMENT - A HYPOTHESIS OF ANTIDEPRESSIVE ACTION
Autore:
PLAZNIK A; KOSTOWSKI W;
Indirizzi:
INST PSYCHIAT & NEUROL,DEPT PHARMACOL & PHYSIOL NERVOUS SYST,A1 SOBIESKIEGO 1-9 PL-02957 WARSAW POLAND
Titolo Testata:
Human psychopharmacology
fascicolo: 1, volume: 8, anno: 1993,
pagine: 1 - 7
SICI:
0885-6222(1993)8:1<1:CAASOA>2.0.ZU;2-R
Fonte:
ISI
Lingua:
ENG
Soggetto:
DESIPRAMINE TREATMENT; RAT-BRAIN; NEUROTRANSMITTER RECEPTORS; ELECTROCONVULSIVE-THERAPY; SEROTONERGIC MECHANISMS; SUICIDE VICTIMS; SENSITIVITY; CLONIDINE; BINDING; SYSTEM;
Keywords:
ANTIDEPRESSANT DRUGS; ELECTROCONVULSIVE SHOCKS; ADAPTIVE RECEPTOR CHANGES; CLINICAL DATA; PRECLINICAL STUDIES;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
55
Recensione:
Indirizzi per estratti:
Citazione:
A. Plaznik e W. Kostowski, "CLINICAL-DATA AND ANIMAL STUDIES ON ADAPTIVE RECEPTOR CHANGES OCCURRING IN DEPRESSION AND AFTER ANTIDEPRESSIVE TREATMENT - A HYPOTHESIS OF ANTIDEPRESSIVE ACTION", Human psychopharmacology, 8(1), 1993, pp. 1-7

Abstract

The clinical and animal studies on the effects of antidepressant treatments on receptor-related changes in the functioning of central neurotransmitter systems, are reviewed. The great variability in individualclinical responses make it impossible to formulate one coherent hypothesis about adaptive receptor changes occurring in human beings. Nevertheless, it is concluded that neuroadaptive responses found in the catecholaminergic systems (dopaminergic and adrenergic alpha-1 receptors)might be important as the underlying mechanism for therapeutic efficacy in depression of antidepressant drugs (AD) and electroconvulsive shock treatment (ECS). The animal studies conducted in our laboratory over the last decade provide evidence for the existence of limbic neurotransmitter modulatory mechanism of action of AD and ECS. It is suggested that at least in the limbic areas (i.e. in the hippocampus and nucleus accumbens, the main structures of the mesolimbic system), AD and ECS produce bidirectional effects. On the one hand they were found to reduce 'inhibitory' signals mediated through serotonergic, GABA-ergic and alpha-2 adrenergic receptors while on the other hand they enhanced 'excitatory' central processes mediated via the dopaminergic and adrenergic alpha-1 receptors. Confirmation of this hypothesis was obtained from behavioral experiments (locomotor and exploratory activity), consisting of microinjections of selective receptor agonists and antagonists into the hippocampus and nucleus accumbens, following the chronic administration of different AD's and ECS. We propose, therefore, that the mechanism of action of antidepressant therapies should be considered from the anatomical and receptor viewpoint, the crucial element being the 'tuning' of the signals within the limbic areas. The consequenceof this mechanism is an enhancement of these processes which can be defined as 'activatory', in terms of their mood elevating effects. The final effect of antidepressant therapy emerges as a result of transmitter interactions and disinhibitory processes The 'limbic modulatory neurotransmitter mechanism' is thus suggested to be responsible for the effect of antidepressant treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/07/20 alle ore 19:54:31